Dec 13, 2023
Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation
Read More
Sep 26, 2023
Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation
Read More
Sep 26, 2023
Cardiosense Begins Enrollment in Nationwide Heart Failure Study
Read More
Aug 8, 2023
Nyra Medical names Lori Chmura as Chief Executive Officer
Read More
Jun 20, 2023
HAYA Therapeutics Adds Douglas L. Mann, M.D. as Chairperson of Clinical Advisory Board
Read More
Mar 14, 2023
Acesion Pharma Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met
Read More
567891011